Reuters logo
BRIEF-Sangamo Therapeutics reports Q2 loss per share $0.17
2017年8月9日 / 晚上8点18分 / 1 个月前

BRIEF-Sangamo Therapeutics reports Q2 loss per share $0.17

Aug 10 (Reuters) - Sangamo Therapeutics Inc-

* Sangamo Therapeutics reports second quarter 2017 financial results

* Q2 revenue $8.3 million versus $3.7 million

* Q2 loss per share $0.17

* Sees FY 2017 revenue $30 million to $40 million

* Q2 revenue view $6 million -- Thomson Reuters I/B/E/S

* Q2 earnings per share view $-0.19 -- Thomson Reuters I/B/E/S

* Sangamo Therapeutics Inc - Sangamo expects that operating expenses will be in range of $90 million to $100 million for 2017

* Sangamo Therapeutics Inc - Sangamo expects that its cash, cash equivalents and marketable securities will be at least $220 million at end of 2017

* Q2 earnings per share view $-0.19, revenue view $6.0 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below